These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 29126740

  • 1. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
    Singh S, Shams Hakimi C, Jeppsson A, Hesse C.
    Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.
    Gravemann U, Volgmann T, Min K, Philipp R, Lambrecht B, Müller TH, Seltsam A.
    Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807
    [Abstract] [Full Text] [Related]

  • 4. Soluble CD40L and CD62P levels differ in single-donor apheresis platelet concentrates and buffy coat-derived pooled platelet concentrates.
    Sut C, Tariket S, Aloui C, Arthaud CA, Eyraud MA, Fagan J, Chavarin P, Hamzeh-Cognasse H, Laradi S, Garraud O, Cognasse F.
    Transfusion; 2019 Jan; 59(1):16-20. PubMed ID: 30291753
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system.
    Plaza EM, Céspedes P, Fernández H, Sánchez-Guiu MI, Egea JM, Vicente V, Lozano ML, Rivera J.
    Vox Sang; 2014 Jan; 106(1):38-44. PubMed ID: 23888911
    [Abstract] [Full Text] [Related]

  • 7. In vitro assessment of platelet concentrates with multiple electrode aggregometry.
    Shams Hakimi C, Hesse C, Wallén H, Boulund F, Grahn A, Jeppsson A.
    Platelets; 2015 Jan; 26(2):132-7. PubMed ID: 24999542
    [Abstract] [Full Text] [Related]

  • 8. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF.
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer.
    Wagner SJ, Seetharaman S, Kurtz J.
    Transfusion; 2012 Nov; 52(11):2427-31. PubMed ID: 22452313
    [Abstract] [Full Text] [Related]

  • 11. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
    Albanyan AM, Harrison P, Murphy MF.
    Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of platelet quality obtained using conventional methods or from buffy-coat and stored at room temperature].
    Dzieciatkowska A, Fuskiewicz M, Ziemba-Zółowska B, Sabliński J.
    Acta Haematol Pol; 1994 Jan; 25(2):135-43. PubMed ID: 8067184
    [Abstract] [Full Text] [Related]

  • 13. Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs.
    Beshkar P, Hosseini E, Ghasemzadeh M.
    Transfus Apher Sci; 2018 Feb; 57(1):76-81. PubMed ID: 29292029
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometry analysis of platelet populations: usefulness for monitoringthe storage lesion in pooled buffy-coat platelet concentrates.
    Vučetić D, Ilić V, Vojvodić D, Subota V, Todorović M, Balint B.
    Blood Transfus; 2018 Jan; 16(1):83-92. PubMed ID: 28166864
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E, Figueiredo AC, Seghatchian J.
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [Abstract] [Full Text] [Related]

  • 17. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
    Krailadsiri P, Seghatchian J.
    Vox Sang; 2000 Aug; 78(3):171-5. PubMed ID: 10838518
    [Abstract] [Full Text] [Related]

  • 18. Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences.
    Böck M, Rahrig S, Kunz D, Lutze G, Heim MU.
    Transfus Med; 2002 Oct; 12(5):317-24. PubMed ID: 12383338
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.
    Plaza EM, Lozano ML, Guiu IS, Egea JM, Vicente V, De Terán LC, Rivera J.
    Blood Transfus; 2012 Oct; 10(4):480-9. PubMed ID: 22682335
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.